MedWellAI (MWAI) stock price is $0.28, down 12.50% on the day, as of Oct 14, 2026. It has a market cap of $1.19Mn, and is classified in the Drug Distribution industry (Healthcare sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap1.19 Mn
P/E-0.52
P/S0.83
Div. Yield0.00
Total Debt (Qtr)7.00 Mn
Revenue Growth (1y) (Qtr)119.92
Add ratio to table…
About
MedWellAI, Inc. is a diversified holdings company that develops, acquires, operates, and invests in unique and profitable businesses, with a primary focus on AI driven healthcare and wellness solutions. The company conducts its operations through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products. In addition to its current healthcare focus, MedWellAI previously engaged in digital asset mining activities and held an…
MedWellAI, Inc. is a diversified holdings company that develops, acquires, operates, and invests in unique and profitable businesses, with a primary focus on AI driven healthcare and wellness solutions. The company conducts its operations through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products. In addition to its current healthcare focus, MedWellAI previously engaged in digital asset mining activities and held an interest in an online sales business through Healthy Lifestyle USA LLC, both of which have been discontinued or are no longer pursued due to regulatory hurdles.
MedWellAI generates revenue mainly from product sales on its MedWell USA B2B ecommerce platform and from commission based services. During the fiscal year ended June 30, 2025, the company recorded commission based revenue of $576,931 and online sales revenue of $17,837 before the decision to cease the online sales line. The online sales business, acquired through a 51% stake in Healthy Lifestyle, resulted in a full goodwill impairment of $670,329 due to regulatory challenges. Historically, the company also derived funds from its digital asset mining operations; however, those operations were discontinued, miners were sold, and the activity is reported as discontinued operations. Prior digital assets held as of June 30, 2024 were sufficient to support operations throughout the year ended June 30, 2025.
The company operates through the following segments:
MedWell USA: This segment operates a B2B ecommerce platform that distributes pharmaceutical products, with a special emphasis on GLP medications used for weight loss and diabetes management. The platform incorporates an AI powered ordering system, provides real time inventory tracking, offers smart suggestions for product selection, and delivers dedicated support to healthcare providers such as wellness clinics, med spas, and corporate wellness facilities.
MedWellAI holds a niche position in the AI driven healthcare distribution market. Its competitive advantages stem from the integration of AI powered ordering technology, real time inventory capabilities, and a concentrated focus on GLP medications, which together improve efficiency and reliability for medical customers. The company faces competition from other healthcare ecommerce platforms and health technology firms that offer similar digital ordering and inventory management solutions.
MedWellAI serves a customer base composed of wellness clinics, med spas, and corporate wellness facilities that require dependable access to pharmaceutical products and AI supported ordering tools. Prior to the discontinuation of its online sales line, the company also served individual consumers through the Healthy Lifestyle venture.
Sector:HealthcareSector rationaleThe company's dominant business line is MedWell USA, which operates a B2B ecommerce platform for distributing pharmaceutical products, specifically GLP medications, to healthcare providers like wellness clinics and med spas. This activity falls directly under the 'Drug Distribution' industry within the Healthcare sector. While the platform uses AI, the revenue is generated from the sale and distribution of medical products, and previous activities in digital asset mining and consumer sales have been discontinued.Industry:Drug DistributionDrug DistributionPrimaryMedWellAI operates through its subsidiary MedWell USA, which runs a B2B ecommerce platform for distributing pharmaceutical products, specifically GLP medications. Its primary revenue is generated from product sales to healthcare providers such as wellness clinics and med spas.Classified using BQ-MICSCIK: 0001520118
Statement Class Of Stock Axis Breakdown of Revenue (2025)